Abstract
Objective
To find out if there is an association between hyperglycaemia and mortality in mixed ICU patients.
Design and setting
Retrospective cohort study over a 2-year period at the medical ICU of a university hospital.
Measurements
Admission glucose, maximum and mean glucose, length of stay, mortality, insulin therapy and Apache-II score.
Results
In 1085 consecutive patients, ICU- and hospital mortality were 20 and 25%, respectively. The total number of blood glucose measurements was 10.012. Admission glucose was 7.9 ± 4.5 mmol/l (mean ± SD), mean glucose 7.5 ± 2.9 and maximum glucose 10.0 ± 5.4 mmol/l. Median ICU length of stay (LOS) was 3.0 days (range 2.0–6.0 days, IQR), and hospital LOS was 16 days (range 7–32 days). In 28% of patients insulin treatment was started. Median Apache-II score was 13. 68% of patients were mechanically ventilated. Univariate analysis showed an association with ICU mortality for mean glucose (non-survivors 8.6 ± 4.3 vs 7.2 ± 2.4 survivors), maximum glucose (11.7 ± 5.9 vs 9.6 ± 5.2, non-survivors vs survivors, respectively), use of insulin (mortality 29 vs 17% in patients not using insulin) and age (61 vs 55.7 years). Gender and a history of diabetes mellitus were not associated with mortality. In a multivariate model, the Apache-II score was the only variable associated with mortality independent of other variables, including mean blood glucose.
Conclusion
In this retrospective study mean glucose level was not an independent risk factor for mortality in mixed ICU patients.
Similar content being viewed by others
References
van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367
van der Horst IC, Gans RO, Nijsten MW, Ligtenberg JJ (2003) Beneficial effect of glucose-insulin-potassium infusion in noncritically ill patients has to be proven. J Intern Med 254:513
van der Horst IC, Gans RO, Zijlstra F, Ligtenberg JJ (2004) Exogenous insulin and hypoglycemia as prognostic factors in critically ill patients. J Am Med Assoc 291:558–559
van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P (2003) Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 31:359–366
Krinsley JS (2003) Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 78:1471–1478
Christiansen C, Toft P, Jorgensen HS, Andersen SK, Tonnesen E (2004) Hyperglycaemia and mortality in critically ill patients. A prospective study. Intensive Care Med 30:1685–1688
Whitcomb BW, Pradhan EK, Pittas AG, Roghmann MC, Perencevich EN (2005) Impact of admission hyperglycemia on hospital mortality in various intensive care unit populations. Crit Care Med 33:2772–2777
Krinsley JS (2004) Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 79:992–1000
Acknowledgements
We thank P. Dijkstra for expert statistical advice, M. van der Tuuk for providing us with data from the hospital information system and the ICU nursing staff for their cooperation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ligtenberg, J.J.M., Meijering, S., Stienstra, Y. et al. Mean glucose level is not an independent risk factor for mortality in mixed ICU patients. Intensive Care Med 32, 435–438 (2006). https://doi.org/10.1007/s00134-005-0052-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-005-0052-y